| [1] |
阮韦淑怡，陆远强，何文炯，等.构建老龄急危重症患者救治过程中和谐医患关系的管理思路探讨[J/CD].中华危重症医学杂志（电子版），2017，10（2）：73-75.
|
| [2] |
Sia AT, Lim Y, Lim EC, et al. A118G single nucleotide polymorphism of human mu-opioid receptor gene influences pain perception and patient-controlled intravenous morphine consumption after intrathecal morphine for postcesarean analgesia[J]. Anesthesiology, 2008, 109 (3): 520-526.
|
| [3] |
Li JL, Liu S, Fu Q, et al. Interactive effects of CYP3A4, CYP3A5, MDR1 and NR1I2 polymorphisms on tracrolimus trough concentrations in early postrenal transplant recipients[J]. Pharmacogenomics, 2015, 16 (12): 1355-1365.
|
| [4] |
Okubo M, Murayama N, Shimizu M, et al. CYP3A4 intron 6 C>T polymorphism (CYP3A4*22) is associated with reduced CYP3A4 protein level and function in human liver microsomes[J]. J Toxicol Sci, 2013, 38 (3): 349-354.
|
| [5] |
Bijker JB, Persoon S, Peelen LM, et al. Intraoperative hypotension and perioperative ischemic stroke after general surgery: a nested case-control study[J]. Aneasthesiology, 2012, 116 (3): 658-664.
|
| [6] |
李晖，李清，杨风顺，等. 多模式镇痛对老年髋部骨折术后谵妄影响的研究[J]. 中国骨科杂志，2013，33（7）：736-740.
|
| [7] |
Huang M, Wang HM, Guo Y, et al. Single nucleotide polymorphism of CYP3A4 intron 2 and its influence on CYP3A4 mRNA expression and liver enzymatic activity in human liver[J]. J Huazhong Univ Sci Technolog Med Sci, 2015, 35 (4): 502-507.
|
| [8] |
Denisov IG, Grinkova YV, Baylon JL, et al. Mechanism of drug-drug interactions mediated by human cytochrome P450 CYP3A4 monomer[J]. Biochemistry, 2015, 54 (13): 2227-2239.
|
| [9] |
Awortwe C, Manda VK, Avonto C, et al. In vitro evaluation of reversible and time-dependent inhibitory effects of kalanchoe crenata on CYP2C19 and CYP3A4 activities[J]. Drug Metab Lett, 2015, 9 (1): 48-62.
|
| [10] |
Zhang W, Chang YZ, Kan QC, et al. CYP3A4*1G genetic polymorphism influences CYP3A activity and response to fentanyl in Chinese gynecologic patients[J]. Eur J Clin Pharmacol, 2010, 66 (1): 61-66.
|
| [11] |
Richards-Waugh LL, Primerano DA, Dementieva Y, et al. Fatal methadone toxicity: potential role of CYP3A4 genetic polymorphism[J]. J Anal Toxicol, 2014, 38 (8): 541-547.
|
| [12] |
Erratico CA, Deo AK, Bandiera SM. Regioselective Versatility of Monooxygenase Reactions Catalyzed by CYP2B6 and CYP3A4: Examples with Single Substrates[J]. Adv Exp Med Biol, 2015 (851): 131-149.
|
| [13] |
Zhang W, Yuan JJ, Kan QC, et al. Influence of CYP3A5*3 polymorphism and interaction between CYP3A5*3 and CYP3A4*1G polymorphisms on post-operative fentanyl analgesia in Chinese patients undergoing gynaecological surgery[J]. Eur J Anaesthesiol, 2011, 28 (4): 245-250.
|
| [14] |
张卫，张豪勇，阚全程，等. CYP3A4*1G基因多态性对女性健康志愿者芬太尼药效学的影响[J].中华麻醉学杂志，2012，32（1）：67-69.
|
| [15] |
Hamilton M, Wolf JL, Drolet DW, et al. The effect of rifampicin, a prototypical CYP3A4 inducer, on erlotinib pharmacokinetics in healthy subjects[J]. Cancer Chemother Pharmacol, 2014, 73 (3): 613-621.
|
| [16] |
Kurzawski M, Dabrowska J, Dziewanowski K, et al. CYP3A5 and CYP3A4, but not ABCB1 polymorphisms affect tacrolimus dose-adjusted trough concentrations in kidney transplant recipients[J]. Pharmacogenomics, 2014, 15 (2): 179-188.
|
| [17] |
Kohlrausch FB, Carracedo A, Hutz MH. Characte-rization of CYP1A2, CYP2C19, CYP3A4 and CYP3A5 polymorphisms in South Brazilians[J]. Mol Biol Rep, 2014, 41 (3): 1453-1460.
|